JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us
Esta página ha sido traducida por una máquina. Otras páginas pueden seguir apareciendo en inglés. View in English

Desarrollo de quimeras dirigidas a lisosomas de doble receptor para la degradación de proteínas

  • 0State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.
Journal of the American Chemical Society +

|

23 de octubre de 2025

|

23 de octubre de 2025

Ver abstracta en PubMed

Resumen

Este resumen es generado por máquina.

Este estudio introduce una estrategia de doble orientación utilizando quimeras que se dirigen a los lisosomas (LYTAC) para degradar las proteínas que causan enfermedades como PD-L1 y EGFR. Este nuevo enfoque mejora la degradación dirigida de proteínas para posibles terapias contra el cáncer.

Área De La Ciencia

  • La bioquímica
  • Biología molecular
  • En el campo de la oncología

Sus Antecedentes

  • Las quimeras dirigidas a lisosomas (LYTAC) son terapias emergentes para la degradación dirigida de proteínas.
  • Las estrategias LYTAC actuales se enfrentan a limitaciones en la degradación de proteínas extracelulares y de membrana específicas.

Objetivo Del Estudio

  • Desarrollar una nueva estrategia de degradación de proteínas dependiente de los receptores dirigidos a los lisosomas.
  • Crear LYTAC de doble receptor para la degradación eficiente del ligando de muerte celular programada 1 (PD-L1) y el receptor del factor de crecimiento epidérmico (EGFR).

Principales Métodos

  • Apalancado las acciones sinérgicas del receptor de quimiocinas C-X-C 4 (CXCR4) y el receptor de folato 1 (FOLR1).
  • LYTACs de doble receptor diseñados y probados para la degradación de PD-L1 y EGFR.
  • Eficacia evaluada en modelos preclínicos de cáncer de pulmón inducido por EGFR.

Principales Resultados

  • Se ha logrado una degradación lisosómica eficiente de PD-L1 y EGFR utilizando LYTAC de receptor dual.
  • La quimera dirigida al EGFR demostró una inhibición significativa del crecimiento del cáncer de pulmón resistente a los fármacos.
  • La estrategia de doble orientación mostró una degradación proteica superior en comparación con los LYTAC de un solo receptor.

Conclusiones

  • La estrategia LYTAC de doble orientación ofrece capacidades mejoradas de degradación de proteínas.
  • Esta nueva plataforma es prometedora para el desarrollo de terapias avanzadas contra el cáncer.
  • La orientación de receptores duales representa un avance significativo en las estrategias de degradación de proteínas para el tratamiento de enfermedades.

Videos de Conceptos Relacionados

Regulated Protein Degradation 02:58

8.7K

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...

Delivery Pathways to the Lysosome 01:36

8.8K

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...

Lysosomal Hydrolases 01:22

4.4K

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...

Receptor-mediated Endocytosis 01:39

110.5K

Overview

Receptor-mediated endocytosis is a process through which bulk amounts of specific molecules can be imported into a cell after binding to cell surface receptors. The molecules bound to these receptors are taken into the cell through inward folding of the cell surface membrane, which is eventually pinched off into a vesicle within the cell. Structural proteins, such as clathrin, coat the budding vesicle and give it its round form.

Clathrin-Mediated Endocytosis of LDL

One...

Receptor-mediated Endocytosis 01:20

7.5K

Receptor-mediated endocytosis is when bulk amounts of specific molecules are imported into a cell after binding to cell surface receptors. The molecules bound to these receptors are taken into the cell through inward folding of the cell surface membrane, which is eventually pinched off into a vesicle within the cell. Structural proteins, such as clathrin, coat the budding vesicle.
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...

Export of Misfolded Proteins out of the ER 01:32

5.0K

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...